CYP26C1: Difference between revisions
New page: {{protein |Name=cytochrome P450, family 26, subfamily C, polypeptide 1 |caption= |image= |width= |HGNCid=20577 |Symbol=CYP26C1 |AltSymbols= |EntrezGene=340665 |OMIM= 608428 |RefSeq=NM_1833... |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 19: | Line 19: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''CYP26C1''' ('''cy'''tochrome '''P'''450, family '''26''', subfamily '''c''', polypeptide '''1''') is a [[protein]] which in humans is encoded by the ''CYP26C1'' ''gene''.<ref name="pmid14532297">{{cite journal | author = Taimi M, Helvig C, Wisniewski J, ''et al'' | title = A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid | journal = J. Biol. Chem. | volume = 279 | issue = 1 | pages = 77–85 | year = 2004 | month = January | pmid = 14532297 | doi = 10.1074/jbc.M308337200 | url = | issn = }}</ref> | '''CYP26C1''' ('''cy'''tochrome '''P'''450, family '''26''', subfamily '''c''', polypeptide '''1''') is a [[protein]] which in humans is encoded by the ''CYP26C1'' ''gene''.<ref name="pmid14532297">{{cite journal | author = Taimi M, Helvig C, Wisniewski J, ''et al'' | title = A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid | journal = J. Biol. Chem. | volume = 279 | issue = 1 | pages = 77–85 | year = 2004 | month = January | pmid = 14532297 | doi = 10.1074/jbc.M308337200 | url = | issn = }}</ref> | ||
| Line 27: | Line 27: | ||
{{NLM content}} | {{NLM content}} | ||
{{Cytochrome P450}} | {{Cytochrome P450}} | ||
{{WH}] | {{WH}] | ||
{{WS}} | {{WS}} | ||
Revision as of 23:18, 8 August 2012
| cytochrome P450, family 26, subfamily C, polypeptide 1 | |
|---|---|
| Identifiers | |
| Symbol | CYP26C1 |
| Entrez | 340665 |
| HUGO | 20577 |
| OMIM | 608428 |
| RefSeq | NM_183374 |
| UniProt | Q6V0L0 |
| Other data | |
| Locus | Chr. 10 q23.33 |
|
WikiDoc Resources for CYP26C1 |
|
Articles |
|---|
|
Most recent articles on CYP26C1 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CYP26C1 at Clinical Trials.gov Clinical Trials on CYP26C1 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CYP26C1
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating CYP26C1 Risk calculators and risk factors for CYP26C1
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CYP26C1 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
CYP26C1 (cytochrome P450, family 26, subfamily c, polypeptide 1) is a protein which in humans is encoded by the CYP26C1 gene.[1]
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is involved in the catabolism of all-trans- and 9-cis-retinoic acid, and thus contributes to the regulation of retinoic acid levels in cells and tissues.[2]
References
- ↑ Taimi M, Helvig C, Wisniewski J; et al. (2004). "A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid". J. Biol. Chem. 279 (1): 77–85. doi:10.1074/jbc.M308337200. PMID 14532297. Unknown parameter
|month=ignored (help) - ↑ "Entrez Gene: CYP26C1".
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
{{WH}] Template:WS